|
Our story is yours to share.
2002
 |
April - The Company is founded under the name BioCell Innovations. |
|
May -The Company acquires its original patent licensing rights through a novation from NASA. (Note: Research on the Regenetech NASA licensed bioreactor went as far back as shuttle STS-95 with John Glenn's work.) |
|
May - Regenetech enters into a Sponsored Research Agreement with M.D. Anderson Cancer Center in Houston, Texas. |
|
August - Regenetech files its first patent |
|
November - BioCell Innovations changes its name to Regenetech, Inc. |
2003
|
January - Stage 1 research is fully completed; Regenetech licenses its first intellectual property for treatment of Sickle Cell Anemia. |
|
April - Regenetech licenses an additional two (2) patents from NASA relating to advanced bioreactor technology. |
|
April - Regenetech enters into a Reimbursable Space Act Agreement with NASA to continue development of adult stem cell expansion. |
2005
|
January - Regenetech confirms its significantly expanded adult stem cells were free from cancer risks and had no genetic modification. |
2005 - 2006
|
Regenetech expands its research at NASA and several universities and completes the filing of its first 73 patent applications. |
2007
|
August - Regenetech achieves 70 fold expansion of peripheral blood adult stem cells. |
2008
|
Regenetech enters into licensing agreement with Korea Stem Cell Bank. |
|
August - Regenetech enters into license with Cellgenia⃨ of Greece. |
|
December - Regenetech enters into license with Magnafix. Dec 2008 |
2009
|
June - Regenetech achieves 100 fold expansion of Mesenchymal Adult stem cells. |
|
June -Regenetech enters into license with HCA. |
|
July - Regenetech announces $100M acquisition by Healthcare of Today, Inc. Company remains a fully-integrated subsidiary. * |
* Pending completion of Healthcare of Today’s IPO, necessary votes, and any other legal requirements applicably by law, Regenetech will join Healthcare of Today.
|